Aisling Capital Management LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,316,806 | 1,316,806 | 0 | 27,666,094 | 30,760,588 | 6.46% | +3,094,494 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,555,664 | +83,333 | 23,086,150 | 25,590,673 | 5.37% | +2,504,523 |
| Eupraxia Pharmaceuticals Inc. (EPRX) | 0 | 325,000 | +325,000 | 0 | 2,353,000 | 0.49% | +2,353,000 |
| BridgeBio Oncology Therapeutics (BBOT) | 564,625 | 1,018,018 | +453,393 | 7,069,105 | 9,111,261 | 1.91% | +2,042,156 |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | 9,574,907 | 11,315,799 | 2.38% | +1,740,892 |
| Biomea Fusion Inc (BMEA) | 2,048,757 | 2,048,757 | 0 | 2,540,459 | 3,134,598 | 0.66% | +594,139 |
| Scholar Rock Holding Corporation (SRRK)(SRRK) | 77,031 | 77,031 | 0 | 3,393,216 | 3,786,844 | 0.80% | +393,628 |
| Aclaris Therapeutics Inc (ACRS) | 434,455 | 434,455 | 0 | 1,307,710 | 1,629,206 | 0.34% | +321,496 |
| OnKure Therapeutics, Inc. (OKUR) | 88,607 | 88,607 | 0 | 256,960 | 366,833 | 0.08% | +109,873 |
| Marker Therapeutics, Inc. (MRKR) | 325,370 | 325,370 | 0 | 484,801 | 422,981 | 0.09% | -61,820 |
| Compass Pathways Plc (CMPS)(CMPS) | 1,198,418 | 1,432,336 | +233,918 | 8,269,084 | 7,920,818 | 1.66% | -348,266 |
| Urogen Pharma Ltd. (URGN)(URGN) | 108,000 | 108,000 | 0 | 2,529,360 | 1,941,840 | 0.41% | -587,520 |
| CalciMedica, Inc. (CALC) | 521,114 | 0 | -521,114 | 3,434,141 | 0 | — | -3,434,141 |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 5,089,611 | 5,089,611 | 0 | 389,304,345 | 377,954,513 | 79.35% | -11,349,832 |